A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam

Background: COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There is currently no vaccine to prevent COVID-19 or therapeutic agent to treat COVID-19. This clinical trial is designed to evaluate chloroquine as a potential th...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Wellcome Open Res
Κύριοι συγγραφείς: Kestelyn, Evelyne, Dung, Nguyen Thi Phuong, Lam Minh, Yen, Hung, Le Manh, Quan, Nguyen Minh, Dung, Nguyen Thanh, Minh, Ngo Ngoc Quang, Xuan, Tran Chanh, Phong, Nguyen Thanh, Ninh Thi Thanh, Van, Donovan, Joseph, Tu, Tran Nguyen Hoang, Nhat, Le Thanh Hoang, Truong, Nguyen Thanh, Man, Dinh Nguyen Huy, Thao, Huynh Phuong, Ngoc, Nghiêm My, Lam, Vo Thanh, Phat, Huynh Hong, Phuong, Phan Minh, Geskus, Ronald B., Ha, Vo Thi Nhi, Quang, Nguyen Ngo, Tran Tinh, Hien, Tan, Le Van, Thwaites, Guy E., Day, Jeremy N., Chau, Nguyen Van Vinh
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: F1000 Research Limited 2020
Θέματα:
Study Protocol
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7573712/
https://ncbi.nlm.nih.gov/pubmed/33110944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.15936.1
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια